Effects of ozonation on mutagenic activity of polycyclic aromatic hydrocarbons.
Fouillet
B
B
Faculty of Pharmaceutical Sciences, Department of Toxicology, Lyon, France.
Chambon
P
P
Chambon
R
R
Castegnaro
M
M
Weill
N
N
D015127:9,10-Dimethyl-1,2-benzanthracene / Q000378:metabolism / Q000633:toxicity; D001564:Benzo(a)pyrene / Q000378:metabolism / Q000633:toxicity; D001711:Biotransformation; D002851:Chromatography, High Pressure Liquid; D002911:Chrysenes / Q000378:metabolism / Q000633:toxicity; D005470:Fluorometry; D008748:Methylcholanthrene / Q000378:metabolism / Q000633:toxicity; D009152:Mutagenicity Tests; D010126:Ozone / Q000378:metabolism / Q000494:pharmacology*; D011083:Polycyclic Compounds / Q000378:metabolism / Q000633:toxicity*; D012486:Salmonella typhimurium / Q000187:drug effects / Q000235:genetics; D013056:Spectrophotometry, Ultraviolet
D002911:Chrysenes; D011083:Polycyclic Compounds; C031180:chrysene; D001564:Benzo(a)pyrene; D008748:Methylcholanthrene; D015127:9,10-Dimethyl-1,2-benzanthracene; D010126:Ozone